David F.

David Friedman is a Managing Director at Suvretta Capital Management, LLC, where he leads investment strategy and execution across key sectors. Leveraging his extensive background in both finance and medicine, he provides guidance in portfolio management, risk analysis, and firm leadership, shaping the firm's overall investment approach.

At Suvretta, David focuses on diverse asset classes with particular expertise in healthcare and biotechnology, drawing on his scientific training and market insight to evaluate investment opportunities in these industries. His multidisciplinary perspective is instrumental in identifying high-growth companies and navigating complex regulatory and innovation landscapes, giving the firm a competitive edge in the sector.

David holds an MBA from Harvard Business School, an MD from the University of Pittsburgh School of Medicine, and a BS in Biology from Duke University. His notable career prior to Suvretta includes leadership roles in finance and healthcare, consistently contributing to the advancement of investment practices and generating value for institutional clients.